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ESMO is Europe’s leading medical oncology society, providing a professional network
for its members and working with national societies across Europe and around the
world. As of today, Japanese oncology professionals represent the 6th largest
membership group within ESMOmembership; with 286 abstracts submitted and 595
congress attendees, the Japanese oncology community significantly contributed to the
success of the last ESMO 2014 Congress in Madrid. Being the official journal of both
societies, Annals of Oncology, now ranked in the top 20 journals in the Science
Citation Index, dramatically contributed to the dissemination of oncology knowledge
and contributes to knowledge sharing between the European and Asian oncology
community. The 2015 nomination of an ESMO National Representative for Japan is a
further step to ensure that the voice of the Japanese oncology community is heard at a
European level and that the two societies can actively collaborate on joint international
research initiatives such as the “ESMO-led Global Opioid Initiative” and the “ESMO
International Consortium study on the Availability of Anti-neoplastic Medicines”.
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